Back to Results
First PageMeta Content
Acetylcholinesterase inhibitors / Nootropics / Benzazepines / Galantamine / Janssen Pharmaceutica / Zoledronic acid / Octreotide / Pharmaceutical drug / Pefloxacin / Chemistry / Organic chemistry / Alcohols


Updates to the Alberta Human Services Drug Benefit Supplement Effective August 1, 2014 Inquiries should be directed to:
Add to Reading List

Document Date: 2014-07-25 18:04:21

Open Document

File Size: 226,55 KB

Share Result on Facebook

Company

Pharmacy Services / ABC / TEVA / Alberta Human Services / Blue Cross 10009 108 Street NW Edmonton AB / /

Currency

USD / /

Event

Person Communication and Meetings / /

Facility

Pharmacy Services Alberta Blue Cross / /

/

IndustryTerm

treatment of Alzheimer's disease / diagnostic tool / /

MedicalCondition

MS disease modifying therapy / Special Authorization ALBERTA HUMAN SERVICES DRUG BENEFIT SUPPLEMENT UPDATE CRITERIA FOR SPECIAL AUTHORIZATION OF SELECT DRUG PRODUCTS DIMETHYL FUMARATE Relapsing Remitting Multiple Sclerosis / acromegaly / fever / Alzheimer's disease / vasoactive intestinal peptidesecreting tumors / active disease / short bowel syndrome / AIDS / metastatic carcinoid / MS / remitting multiple sclerosis / intractable diarrhea / /

MedicalTreatment

General Surgery / /

Organization

Alberta government / UNIT OF ISSUE / /

Person

DIN MFR CEFPROZIL / DIN MFR RESOURCE KID ESSENTIALS / DIN MFR TECFIDERA / PAT-GALANTAMINE ER / PAT PMS TEV JAI / Alberta Drug / /

/

Position

registered MS Neurologist / Specialist / General / MS Neurologist / /

Product

MG ORAL DELAYED-RELEASE CAPSULE / EXTENDED-RELEASE CAPSULE / CEFPROZIL / MG ORAL TABLET / donepezil / ORAL EXTENDED-RELEASE CAPSULE / CANDESARTAN CILEXETIL / SANDOSTATIN / OCTREOTIDE ACETATE / CIPROFLOXACIN / ORAL SUSPENSION / MG DELAYEDRELEASE CAPSULE / GALANTAMINE HYDROBROMIDE / rivastigmine / HYDROCHLOROTHIAZIDE / /

ProgrammingLanguage

ML / /

ProvinceOrState

Mississippi / /

Technology

html / MRI / /

URL

http /

SocialTag